Glucocorticoids Enhance or Spare Innate Immunity: Effects in Airway Epithelium Are Mediated by CCAAT/Enhancer Binding Proteins
- 1 July 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 179 (1) , 578-589
Abstract
Although it is widely accepted that glucocorticoids (GC) are a mainstay of the treatment of diseases characterized by airway inflammation, little is known about the effects of GC on local innate immunity. In this article, we report that respiratory epithelial cells manifested a local “acute phase response” after stimulation with TLR activation and TNF-α and that GC spared or enhanced the epithelial expression of molecules that are involved in host defense, including complement, collectins, and other antimicrobial proteins. As expected, GC inhibited the expression of molecules responsible for inflammation such as cytokines (IFNβ and GM-CSF) and chemokines (RANTES and IL-8). Studies using Western blotting, EMSA, and functional analysis indicated that the selective effects of GC are mediated through activation of the transcription factor C/EBP. Knockdown of C/EBPβ by small interfering RNA blocked the enhancement by GC of host defense molecule expression but had no effect on inflammatory gene expression. These results suggest that GC spare or enhance local innate host defense responses in addition to exerting anti-inflammatory actions. It is possible that the known ability of GC to reduce the exacerbation of diseases in which infectious organisms serve as triggering factors (e.g., asthma, allergic bronchopulmonary aspergillosis, and chronic obstructive pulmonary disease) may result in part from enhanced innate immune responses in airway mucosa.Keywords
This publication has 62 references indexed in Scilit:
- Thymulin evokes IL-6-C/EBPβ regenerative repair and TNF-α silencing during endotoxin exposure in fetal lung explantsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Selective Early Production of CCL20, or Macrophage Inflammatory Protein 3α, by Human Mast Cells in Response toPseudomonas aeruginosaInfection and Immunity, 2003
- The Structure of Human Macrophage Inflammatory Protein-3α/CCL20Journal of Biological Chemistry, 2002
- ComplementNew England Journal of Medicine, 2001
- Expression of C-Reactive Protein in the Human Respiratory TractInfection and Immunity, 2001
- Transcriptional Regulation of C/EBPδ in G0 Growth-Arrested Mouse Mammary Epithelial CellsBiochemical and Biophysical Research Communications, 1999
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Activation of the endothelium by IL-1α and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3aClinical and Experimental Immunology, 1995
- The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A proteinImmunology Today, 1994
- The acute phase responseImmunology Today, 1994